Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccine patch
Pharma
Vaccine patch passes clinical test, supporting further trials
Vaxess linked the device to seroprotection rates of over 90% when used to administer an influenza vaccine in a phase 1 trial.
Nick Paul Taylor
Dec 20, 2022 7:30am
Institut Pasteur, Satio ally on intradermal vaccines for Africa
Aug 23, 2022 10:37am
West takes stake in intradermal delivery startup Latch Medical
Aug 16, 2022 9:45am
Vaxxas strikes deal to tee up trial of COVID-19 vaccine patch
Mar 29, 2022 9:04am
MyLife raises cash to advance vaccine patch delivery tech
Nov 16, 2021 10:00am
